Effects of embryo injected with ochratoxins A on hatching quality and jejunum antioxidant capacity of ducks at hatching

Jinhui Liu, Xiayu Jiang, Xin Peng, Yihan Yuan, Shen Yu, Yongxia Li, Zixing Yan, Xi Yuan, Ye Yang, Shuangshuang ZhaiFrontiers in Veterinary Science 2022 · DOI

This study, published in Frontiers in Veterinary Science, explores the hidden toll that mycotoxin contamination takes on avian development. By injecting duck embryos with varying doses of Ochratoxin A (OTA) at different developmental stages, researchers demonstrated that early embryonic exposure significantly impairs hatching weight, weakens the gut’s antioxidant defenses, and triggers localized inflammation.

TL;DR

Researchers found that Ochratoxin A (OTA) exposure during duck embryogenesis—particularly in the early-to-mid stages—reduces hatching weight and compromises intestinal health. The toxin induces oxidative stress and inflammation in the jejunum, potentially handicapping the duckling's growth and immunity from day one.

What Problem Does This Paper Address?

Mycotoxins are toxic secondary metabolites produced by fungi that frequently contaminate animal feed. Among them, Ochratoxin A (OTA) is notorious for causing kidney damage, suppressed immunity, and "enterotoxicity" (gut toxicity) in poultry.

While much is known about how adult birds react to eating contaminated feed, there is a significant knowledge gap regarding in ovo (in-egg) exposure. Because ducks are particularly sensitive to toxins, understanding how the timing and dosage of OTA exposure during incubation affect the duckling's physical quality and gut health is vital for the poultry industry and food safety.

Methods

The researchers employed a 4 × 4 factorial design to isolate the effects of timing and dosage:

  • Subjects: 480 fertilized duck eggs.
  • The Variables:
    • Timing: Injections were performed on embryonic days 8, 13, 18, and 23 (E8, E13, E18, E23).
  • Dosage: Four OTA levels (0, 2, 4, and 8 ng/g of egg).
  • The Procedure: OTA was dissolved in a sodium bicarbonate solution and injected directly into the yolk sac.
  • Metrics: At hatching, the team measured body weight, organ indices, and intestinal morphology (villus height and crypt depth). They also analyzed the jejunum for antioxidant markers like Superoxide Dismutase (SOD) and Malondialdehyde (MDA), as well as proinflammatory cytokines (IL-1β, TNF-α, and IL-6).

Datasets

As this was a controlled laboratory experiment, no external datasets were used. The study generated original primary data from the 480 eggs across 16 treatment groups (each with 6 repeats).

Key Insights and Ideas

  • Developmental Windows Matter: The embryo's sensitivity to OTA is not constant. Exposure at E8 and E13 (early-to-mid development) was far more damaging to hatching weight and antioxidant capacity than exposure at E18 or E23.
  • Biochemical vs. Structural Damage: Interestingly, while OTA wreaked havoc on a biochemical level (oxidative stress and inflammation), it did not significantly alter the physical architecture of the gut (villus height or crypt depth). This suggests that the "machinery" of the gut remains intact, but its internal "chemistry" is compromised.
  • The "Double Whammy" of Oxidative Stress: OTA didn't just lower the levels of protective enzymes (SOD and T-AOC); it actively increased MDA, a marker of lipid peroxidation. This indicates that the toxin is actively damaging cell membranes in the intestine.
  • Inflammatory Spike: The cytokine IL-1β showed a significant increase, particularly in the E13 group, suggesting that mid-stage development is a critical window for the maturation of the embryo's inflammatory response.

Key Results

  • Hatching Weight: Injection timing had a massive impact ($P < 0.0001$). Ducklings injected at E8 and E13 were significantly lighter than those injected later.
  • Antioxidant Capacity: SOD and Total Antioxidant Capacity (T-AOC) were lowest in the E8 and E13 groups. Conversely, the highest levels of MDA (oxidative damage) were found in the E13 group ($P < 0.05$).
  • Inflammation: IL-1β levels were significantly higher in OTA-treated groups compared to the control, with the most pronounced effect seen in the E13 injection group.
  • Organ Index: While most organs were unaffected, the relative weight of the spleen was lower in the E8 group compared to E18, suggesting potential impacts on early immune organ development.

Limitations and Future Work

  • Snapshot in Time: The study only evaluated ducklings at the moment of hatching. It is currently unknown if these birds can recover their antioxidant capacity during the brooding phase or if they suffer lifelong performance deficits.
  • Molecular Pathways: While the study identifies the results of oxidative stress, it does not map the specific signaling pathways (such as Nrf2 or NF-κB) that OTA might be hijacking.
  • Field Realism: The study used direct injection. Future research could look at "maternal carryover," where OTA is naturally deposited into the egg by a hen consuming contaminated feed, to see if the effects are identical.

Summary updated

Abstract

Numerous studies have shown that ochratoxins A (OTA) exerts diverse toxicological effects, namely, hepatotoxicity, nephrotoxicity, genotoxicity, enterotoxicity, and immunotoxicity. The main objective of this study was to investigate the influence of embryonic exposure to OTA by different injection times and OTA doses on hatching quality and jejunal antioxidant capacity of ducks at hatching. In total, 480 fertilized eggs were weighed and randomly assigned into a 4 × 4 factorial design including four OTA doses (0, 2, 4, and 8 ng/g egg) on 8, 13, 18, and 23 of embryonic development (E8, E13, E18, and E23). Each treatment included 6 repeats with 5 eggs per repeat. The results showed that the injection time affected the hatching weight (<i>P</i> < 0.0001). The relative length of the jejunum and ileum on E18 and E23 was lower than on E8 and E13 (<i>P</i> < 0.05). Injection time, doses, and their interaction had no effect on jejunum morphology, namely, villous height (Vh), crypt depth (Cd), and villous height/crypt depth ratio Vh/Cd (<i>P</i> > 0.05). The injection time affected the activities of Superoxide dismutase (SOD) (<i>P</i> < 0.0001), total antioxidant capacity (T-AOC) (<i>P</i> < 0.05) and the malondialdehyde (MDA) content (<i>P</i> < 0.0001). The activity of SOD and T-AOC activities in the jejunum of ducklings injected with OTA at the E8 and E13 was lower than that injected at the E18 (<i>P</i> < 0.05). The highest MDA content was observed in ducklings injected with OTA at the E13 (<i>P</i> < 0.05). The injection time (<i>P</i> < 0.0001), OTA doses and their interaction affected the contents of IL-1β (<i>P</i> < 0.05), which significantly increased especially on E13. In conclusion, the embryo injected with ochratoxins A affected the hatching weight, the relative length of jejunum and ileum, decreased the antioxidant capacity and increased the content of proinflammatory cytokine IL-1β of the jejunum.
BibTeX
@inproceedings{liu2022effects,
  author = {Jinhui Liu and Xiayu Jiang and Xin Peng and Yihan Yuan and Shen Yu and Yongxia Li and Zixing Yan and Xi Yuan and Ye Yang and Shuangshuang Zhai},
  title = {{Effects of embryo injected with ochratoxins A on hatching quality and jejunum antioxidant capacity of ducks at hatching}},
  booktitle = {Frontiers in Veterinary Science},
  year = {2022},
  doi = {10.3389/fvets.2022.944891},
}
Figure